Copovidone Market

Copovidone Market Value And Growth (2023-2028):

Copovidone Market is expected to increase at a significant rate, with a CAGR of 9.4% within a given forecast period (2023-2028).

Copovidone Market Overview:

Copovidone (C32H48N12O15) is an organic molecule with the formula C32H48N12O15. It serves a variety of functions in pharmaceutical goods, including binders and tablet disintegrants. It can be used to boost bioavailability and lower the toxicity of some medications, such as paclitaxel, in its medical-grade version. With the molecular formula C20H28N30, copovidone (PVP-VA) is a copolymer of N-vinylpyrrolidone and vinyl acetate. Copovidone is a povidone derivative that is extensively employed in controlled-release formulations as a fining agent, tablet binder, emulsifier, and part of the matrix materials. In comparison to povidone, this chemical is becoming more popular as a substitute since it is less hygroscopic, more elastic, and has superior plasticity. Copovidone is gaining popularity as a film-forming agent and is being used to improve adhesion, elasticity, and hardness in coating solutions. Because of the advantages it has over other polymers, it is finding a wide range of uses in industries such as industrial, ceramics, adhesives, batteries, and others. This is expected to increase copovidone sales in the global market.

Copovidone Market Growth:

Copovidone sales are predicted to accelerate in the global market as demand for non-toxic, pharmaceutically inactive thickening and binding agents grows across various industries.

REPORT COVERAGE:

Copovidone Market Drivers:

Favourable government rules, policies, and standards boost the market for copovidone. Several regulatory bodies, including the US Food and Drug Administration, have permitted the use of non-toxic and pharmaceutically inactive compounds like copovidone in industries like food and beverage, pharmaceuticals, and personal care and cosmetics. Copovidone is being used as a soluble binder for gelatin capsules and as a dry binder for direct compression tabletting across the pharmaceutical sector, in addition to its excellent moisture barrier and binder qualities. As a result, rising global demand for tablets, pills, and capsules is expected to provide attractive growth prospects in the industry.

Copovidone Market Restraints:

Organic and natural cosmetics and personal care products have become increasingly popular in recent years, particularly in industrialized countries such as the United States, Germany, Japan, the United Kingdom, and others. This is preventing industry companies from using copovidone in their products, lowering market demand. Additionally, side effects linked with excessive copovidone usage, including stomach aches, nausea, diarrhoea, and vomiting, are impeding market sales.

Recent Developments in the Global Copovidone Market:

Sotax, a global leader in high-quality dissolution testing systems, composite assay and content uniformity workstations, and physical tablet testing devices has just established a subsidiary in India, Sotax India Pvt Ltd, with headquarters in Mumbai.

Copovidone Market Segmentation: 

By Function:

• Granulating Agent

• Retarding Agent

• Film-forming Agent

• Lubricant

• Thickening Agent

• Dispersant

• Binding Agent

• Emulsifying Agent

• Fining Agent

• Blocking Agent

By function the Copovidone market can be segmented into Granulating Agent, Retarding Agent, Film-forming Agent, Lubricant, Thickening Agent, Dispersant, Binding Agent, Emulsifying Agent, Fining Agent and Blocking Agent. The granulating agent occupies the largest part of the market share due to the utilisation of copovidone as a direct compression binder as well as a wet granulation binder. Copovidone is frequently used as a film-forming agent in coating solutions. It has good adhesion, flexibility, and hardness, as well as the ability to act as a moisture barrier. As a granulating agent, copovidone has greater plasticity than povidone, is less hygroscopic, and is more elastic. These properties of copovidone as a granulating agent add value to the market growth of copovidone.

By Grade:

• Food Grade

• Pharmaceutical Grade

• Industrial Grade

Based on grade, the copovidone market can be bifurcated into Food Grade, Pharmaceutical Grade and Industrial Grade. The pharmaceutical Grade occupies the largest share of the global copovidone market due to its smaller particle size, this highly effective soluble copovidone for dry binding is specifically designed for roller compaction and dry binding in direct compression formulations. It's used in granulation and as a dry binder in tablets, capsules, and granules, as well as a film-forming agent in tablet coatings and sub coating and topical sprays. Soluble copovidone is a kind of copovidone that can be utilised in hot-melt extrusion procedures and is frequently used for instant release formulations.

By End Use:

• Food & Beverage

• Cosmetics

• Personal Care

• Pharmaceuticals

• Adhesives

• Battery

• Water Treatment

• Others

Based on the end-use, the global copovidone market can be divided into Food and Beverage, Cosmetics, Personal care, Pharmaceuticals, Adhesives, Battery, Water Treatment and Others.

The pharmaceuticals segment is the dominant segment. Copovidone, a povidone analogue, is employed as a tablet binder, a film-former, and in controlled-release formulations as part of the matrix material. Copovidone can be used as a direct compression binder and as a wet granulation binder in tabletting. Copovidone is frequently used as a film-forming agent in coating solutions. It has good adhesion, flexibility, and hardness, as well as the ability to act as a moisture barrier. Copovidone has better plasticity than povidone as a tablet binder, is less hygroscopic, more elastic, and better for film-forming applications than povidone.

Copovidone Market Regional Analysis: 

• North America

During the forecast period 2022-2027, North America is expected to develop at a quick CAGR in the global copovidone market. A significant increase in sales of personal care and cosmetics items is being observed across North America, owing to rising consumer concerns about personal hygiene and expanding consumer spending on improving facial, body, and hair aesthetics. Copovidone is widely utilised as an emulsifier, binder, and thickening agent in toothpaste, moisturisers, shampoos, shaving creams, and other goods, therefore rising sales of these items are expected to boost demand in the North American market.

• APAC

The Asia Pacific region would account for a substantial part of the worldwide copovidone market from 2022 to 2027. The demand for therapeutic medications such as tablets and pills is rapidly expanding in South Asia, owing to the rising burden of disease and the growing use of personalised treatment. As a result, prominent industry companies are focusing on increasing their drug production capacity to meet the rising demand.

For example, Glenmark Life Science, an Indian manufacturer of pharmaceuticals and healthcare products, stated in 2021 that it will invest roughly US$ 78.7 million to more than treble its production capacity in the coming years. Copovidone is widely employed in the creation of capsules, tablets, and pills, so such developments are welcome.

• Latin America

• Europe

• The Middle East and Africa

Copovidone Market Key Players:

1. Nanhang Industrial

2. Merck KGaA

3. Boai NKY Pharmaceuticals Ltd.

4. BASF SE

5. Huangshan Bonsun Pharmaceuticals Co., Ltd.

6. Ashland, Hangzhou Motto Science & Technology Co. Ltd.

7. Shanghai Yuking Water Soluble Material Tech Co. Ltd.